Stocks · News reference
BTIG analyst Ryan Zimmerman maintains Shoulder Innovations (NYSE:SI) with a Buy and raises the price target from $24 to $26.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
On Thursday, Shoulder Innovations (NYSE:SI) discussed second-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to earnings call transcripts
BTIG analyst Ryan Zimmerman maintains Shoulder Innovations (NYSE:SI) with a Buy and raises the price target from $26 to $27.
Filed: 2026-10-08 AccNo: 0001699350-26-000058 Size: 159 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market,